• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Regulatory Action Against Ranbaxy

 

Consent Decree for Toansa, India, Facility
 
Import Alert and Consent Decree for Mohali, India, Facility

Department of Justice Action Against Ranbaxy

  • DOJ News Release: Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, CGMP Violations and False Statements to the FDA (5/13/2013)

 

Consent Decree for Paonta Sahib, Batamandi, and Dewas, India, Facilities and Ohm Laboratories in Gloversville, N.Y.
  • FDA News Release: Department of Justice files consent decree of permanent injunction against Ranbaxy (1/25/2012)
 
Application Integrity Policy Action for Paonta Sahib, India, Facility
 
Import Alert for Dewas and Paonta Sahib, India, Facilities


Additional Warning Letters